aminocaproic acid has been researched along with Bradyarrhythmia in 1 studies
Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jy, W | 1 |
| Gagliano-DeCesare, T | 1 |
| Kett, DH | 1 |
| Horstman, LL | 1 |
| Jimenez, JJ | 1 |
| Ruiz-Dayao, Z | 1 |
| Santos, ES | 1 |
| Ahn, YS | 1 |
1 other study available for aminocaproic acid and Bradyarrhythmia
| Article | Year |
|---|---|
Life-threatening bleeding from refractory acquired FVIII inhibitor successfully treated with rituximab.
Topics: Aged; Aged, 80 and over; Aminocaproic Acid; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-D | 2003 |